Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Laryngeal Neoplasms 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Xerostomia Due to Radiotherapy (Disorder) 1Stroke 1Sleep Initiation and Maintenance Disorders 1Signs and Symptoms 1Pulmonary Disease, Chronic Obstructive 1Patient Acceptance of Health Care 1Pain, Intractable 1Pain 1Oropharyngeal Neoplasms 1Organoids 1Obesity, Abdominal 1Mouth Neoplasms 1Lymphoma, Follicular 1Kidney Failure, Chronic 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Glioma 1Diabetes Mellitus 1Delirium 1Death 1Coronary Artery Disease 1

Interventions

suvorexant 1Therapeutics 1Standard of Care 1Practice Guidelines as Topic 1Patient Portals 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Sleep Initiation and Maintenance Disorders × Standard of Care × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡